tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Srikripa Devarakonda, 23 are a BUY (100%).
Analyst Srikripa Devarakonda works at TRUIST with a stock forecast success ratio of 14.29% fulfilled within 43.14 days on average.
Srikripa Devarakonda’s has documented 49 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CYTK, Cytokinetics at 08-Apr-2024.
Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for KYMR (KYMERA THERAPEUTICS) at 11/3/2023. The price target of $41 was fulfilled within 112 days with a profit of $26.73 (187.32%) receiving and performance score of 16.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
84
$32.26 (62.35%)
92
1 days ago
6/14 (42.86%)
$32.26 (62.35%)
62
Hold
65
$13.26 (25.63%)
65
1 months ago
18/33 (54.55%)
$7.52 (13.08%)
193
Hold
67
$15.26 (29.49%)
84
1 months 12 days ago
2/11 (18.18%)
$8.08 (13.71%)
20
Hold
93
2 months 11 days ago
5/17 (29.41%)
$28.81 (44.88%)
188
Hold
64
$12.26 (23.70%)
68
2 months 11 days ago
9/12 (75%)
$6.11 (10.55%)
57
Which stock is Srikripa Devarakonda is most bullish on?
Which stock is Srikripa Devarakonda is most reserved on?
What Year was the first public recommendation made by Srikripa Devarakonda?
